RC
Rubric Capital Management LP
US US · SEC (Form 4)
Browse the complete record of transactions filed by Rubric Capital Management LP. Director active across 2 companies, notably Heron Therapeutics, INC.. In total, 8 disclosures have been published. Total volume traded: €12.2m. The latest transaction was filed on 16 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations 8 total
946,100 shares
Common Stock, par value $0.01 per share ("Common Stock")
SEC:0000902664-25-004459 · 15 Oct 2025
946,100 shares
Common Stock, par value $0.01 per share ("Common Stock")
SEC:0000902664-25-004459:0 · 15 Oct 2025
€919,117 146,685 shares @ €6.2659 15.1% of flow
Common Stock, par value $0.0001 per share ("Common Stock")
SEC:0001104659-21-150598 · 16 Dec 2021
Ideal exit: 12 Sept 2022 (T+270) €919,117 146,685 shares @ €6.2659 7.6% of flow
Common Stock, par value $0.0001 per share ("Common Stock")
SEC:0001104659-21-150598:0 · 16 Dec 2021
Ideal exit: 12 Sept 2022 (T+270) €1m 187,391 shares @ €6.2593 19.3% of flow
Common Stock, par value $0.0001 per share ("Common Stock")
SEC:0001104659-21-150068 · 13 Dec 2021
Ideal exit: 9 Sept 2022 (T+270) €1m 187,391 shares @ €6.2593 9.6% of flow
Common Stock, par value $0.0001 per share ("Common Stock")
SEC:0001104659-21-150068:0 · 13 Dec 2021
Ideal exit: 9 Sept 2022 (T+270) €4m 560,691 shares @ €7.1127 65.6% of flow
Common Stock, par value $0.0001 per share ("Common Stock")
SEC:0001104659-21-148720 · 8 Dec 2021
Ideal exit: 4 Sept 2022 (T+270) €4m 560,691 shares @ €7.1127 32.8% of flow
Common Stock, par value $0.0001 per share ("Common Stock")
SEC:0001104659-21-148720:0 · 8 Dec 2021
Ideal exit: 4 Sept 2022 (T+270) About Rubric Capital Management LP Rubric Capital Management LP is a director and insider, primarily involved with Heron Therapeutics, INC. and Radius Health, Inc.